These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8614960)

  • 1. Posttransfusion graft-versus-host disease in Japanese newborns.
    Ohto H; Anderson KC
    Transfusion; 1996 Feb; 36(2):117-23. PubMed ID: 8614960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.
    Asai T; Inaba S; Ohto H; Osada K; Suzuki G; Takahashi K; Tadokoro K; Minami M
    Transfus Med; 2000 Dec; 10(4):315-20. PubMed ID: 11123816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.
    Takahashi K; Juji T; Miyamoto M; Uchida S; Akaza T; Tadokoro K; Shibata Y; Ino T; Hidano A
    Lancet; 1994 Mar; 343(8899):700-2. PubMed ID: 7907679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
    Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
    Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted use of T-cell receptor V beta genes in posttransfusion graft-versus-host disease.
    Wang L; Tadokoro K; Tokunaga K; Uchida S; Moriyama S; Bannai M; Mitsunaga S; Takai K; Juji T
    Transfusion; 1997; 37(11-12):1184-91. PubMed ID: 9426644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
    Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
    Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
    Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
    Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous resolution of transfusion-associated graft-versus-host disease.
    Mori S; Matsushita H; Ozaki K; Ishida A; Tokuhira M; Nakajima H; Kizaki M; Sugiura H; Kikuchi A; Handa M
    Transfusion; 1995 May; 35(5):431-5. PubMed ID: 7740616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Newborn With Familial Hemophagocytic Lymphohistiocytosis Complicated With Transfusion Associated Graft Versus Host Disease.
    Ozdemir A; Gunes T; Chiang SCC; Unal E
    J Pediatr Hematol Oncol; 2017 Aug; 39(6):e309-e311. PubMed ID: 28328614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft versus host disease (TAGVHD)--with reference to neonatal period.
    Gokhale SG; Gokhale SS
    J Matern Fetal Neonatal Med; 2015 Apr; 28(6):700-4. PubMed ID: 24871361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.